SCHEMBL4206240

SCHEMBL4206240

O=c1cc(CCO)c2ccc(OCCl)cc2o1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.58
▸ KDM4E B2RXH2 6/20 0.58
▸ HPGD P15428 5/20 0.58
▸ PKM P14618 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ MAPT P10636 3/20 0.56
▸ HSD17B10 Q99714 3/20 0.55
▸ LMNA P02545 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ MAOB P27338 2/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ GAA P10253 2/20 0.52
▸ NPC1 O15118 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6439485 0.83 KDM4E (0.69) ALDH1A1KDM4EHPGDPKMKMT2A
SCHEMBL4211377 0.82 MAOB (0.68) KMT2ATDP1MAOBNPC1HSP90AA1
SCHEMBL4221730 0.80 MAOB (0.82) MAOB
SCHEMBL11946745 0.78 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDPKMKMT2A
SCHEMBL4710499 0.77 CA12 (0.55) ALDH1A1KDM4EHPGDPKMKMT2A
SCHEMBL4215955 0.77 HSD17B3 (0.75) ALDH1A1KDM4EHPGDKMT2AHSD17B10
SCHEMBL15689721 0.77 MAOB (0.62) ALDH1A1KDM4EHPGDPKMKMT2A
SCHEMBL28384155 0.75 KDM4E (0.64) ALDH1A1KDM4EHPGDNPSR1MAPT
SCHEMBL15963915 0.74 LCK (0.70) ALDH1A1KDM4EHPGDPKMKMT2A
SCHEMBL9193551 0.74 HSD17B3 (0.65) ALDH1A1KDM4EHPGDPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives NEWRON PHARMACEUTICALS S.P.A. (IT) 2009-01-01 — — US disclosed
EP-1863784-A1 SUBSTITUTED AMINOALKYL- AND AMIDOALKYL-BENZOPYRAN DERIVATIVES Newron Pharmaceuticals S.p.A. (IT) 2007-12-12 — — EP disclosed
WO-2006102958-A1 SUBSTITUTED AMINOALKYL- AND AMIDOALKYL-BENZOPYRAN DERIVATIVES NEWRON PHARMACEUTICALS S.P.A. (IT) 2006-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives MAOB, MAOA, AOC3 ALDH1A1 368/4885KDM4E 1607/4885HPGD 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback